Farr Kevin M
- SEC CIK
- 0001194262
No open-market purchases or sales filed in the past year.
Current role at each company
- PII Polaris Inc.Directoras of May 5, 2025
- NAGE Niagen Bioscience, Inc.CHIEF FINANCIAL OFFICERas of Aug 12, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Farr Kevin M as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PII Polaris Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2023 (view filing) | Aug 3 | 4 days | Farr Kevin MDirector | SSale | −3.23K | $133.28 | −$429.8K | −18.0%14.6K after | |
| Jul 31, 2023 (view filing) | Jul 27 | 4 days | Farr Kevin MDirector | SSale | −1.61K | $134.33 | −$216.9K | −8.3%17.9K after | |
| Nov 1, 2021 (view filing) | Oct 28 | 4 days | Farr Kevin MDirector | SSale | −10.2K | $115.27 | −$1.17M | −41.5%14.3K after |